The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...
The U.S. is now allowing fractional doses of the Jynneos monkeypox vaccine to be administered via an injection that delivers the dose between, rather than under, layers of skin — an effort that will ...
In a recent study posted to the bioRxiv* preprint server, researchers assessed the efficiency of a controllable self-replicating ribonucleic acid (c-srRNA) vaccine against severe acute respiratory ...
The new intradermal technique requires just a fraction of a vaccine per shot. Some states and jurisdictions are hitting early bumps in their rollout of the U.S. government's new approach to expand ...
The approach, which would require a new emergency authorization, would involve injecting one-fifth of the current dose into the skin instead of a full dose into underlying fat. By Sharon LaFraniere ...
Under the EUA, Jynneos can be administered either intradermally for individuals aged ≥18 years or subcutaneously for individuals aged The Food and Drug Administration (FDA) has granted emergency use ...
First human DNA vaccine First in class thermostable self-amplifying mRNA vaccine GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company engineering precision delivery systems that overcome challenges ...
With many in the gay community clamoring for the monkeypox vaccine this summer, hoping for protection from a virus that causes painful and gruesome lesions, the United States faced a challenge. “The ...
Tropis ID, a WHO pre-qualified needle-free delivery system, is an easy-to-use, precise, intradermal delivery method that has already been successfully used in campaign and house-to-house settings in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results